Please upgrade your browser.
Unraveling Kidney Cancer: Mutations in the Genome Regulation Machinery Identified in Clear Cell Renal Cell Carcinoma
In a new study, scientists have searched for mutations in the gene regions of more than 100 kidney cancer samples, the largest number of samples from a single tumour type to be sequenced to date.
A team of scientists discovered a series of genetic mutations associated to the development of kidney cancer.
At the recent annual NICE (National Institute for Health and Clinical Excellence) conference held in Manchester in December, the James Whale Kidney Cancer Patient Advisory Group was shocked at the language used by Sophie Christie, the Chief Executive of Birmingham North and East PCT. She spoke somewhat callously when describing the pressure new drugs put on the system and went so far as calling palliative care drugs "death deferring."
Fifty-seven-thousand people will be told they have kidney cancer this year 12,000 of them will die from it. Now, doctors are microwaving the cancer to kill it -- and keep it from coming back.
The skin is the window to the body and often, internal disease processes can be associated with cutaneous symptoms. A number of cutaneous signs are linked to internal malignancies and the timely recognition of these signs and their associations with either genodermatoses or paraneoplastic syndromes can significantly impact the prognosis and treatment of patients.
Most of Patrick's game contributions have come on special teams, where he has seven tackles this season. Off the field, he embraced his role in Lift for Life, which raises funds and awareness in the battle against kidney cancer. Patrick served as secretary for the effort, which has raised more than $300,000 the past six years.
Former smokers have a greater risk of developing diabetes than smokers or nonsmokers. But researchers say that's due to the pounds people tend to gain after quitting.
We believe that present report is the first report that ZA monotherapy is effective for lung, pleural and liver metastases from RCC.
A Phase I trial in metastatic renal cell carcinoma with IMP321 alone has been completed.
|Powered by NeonCRM|